0155.KL - Malaysian Genomics Resource Centre Berhad

Kuala Lumpur - Kuala Lumpur Delayed Price. Currency in MYR
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in MYR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/10/2023
Current
3/31/202312/31/20229/30/20226/30/20223/31/2022
Market Cap (intraday)
64.45M76.17M99.61M88.19M107.44M102.47M
Enterprise Value
62.23M74.15M93.30M67.17M86.43M81.77M
Trailing P/E
68.5712.8612.0796.61117.70N/A
Forward P/E
10.2110.6412.14N/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
5.014.524.364.024.895.54
Price/Book (mrq)
1.651.872.632.673.253.30
Enterprise Value/Revenue
4.99109.0556.7917.6213.6516.09
Enterprise Value/EBITDA
78.24-26.37-102.9854.9326.2735.86

Yahoo Finance Plus Essential access required.

Learn more

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-22.66%
S&P500 52-Week Change 314.65%
52 Week High 31.1700
52 Week Low 30.4750
50-Day Moving Average 30.5553
200-Day Moving Average 30.6807

Share Statistics

Avg Vol (3 month) 32.92M
Avg Vol (10 day) 31.02M
Shares Outstanding 5130.21M
Implied Shares Outstanding 6130.21M
Float 866.1M
% Held by Insiders 155.58%
% Held by Institutions 14.31%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 15, 2021
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2022
Most Recent Quarter (mrq)Mar 31, 2023

Profitability

Profit Margin 6.26%
Operating Margin (ttm)-5.50%

Management Effectiveness

Return on Assets (ttm)-1.11%
Return on Equity (ttm)0.92%

Income Statement

Revenue (ttm)12.47M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)-86.60%
Gross Profit (ttm)13.85M
EBITDA 311.95k
Net Income Avi to Common (ttm)780.98k
Diluted EPS (ttm)0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.58M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)1.35M
Total Debt/Equity (mrq)3.44
Current Ratio (mrq)16.56
Book Value Per Share (mrq)0.29

Cash Flow Statement

Operating Cash Flow (ttm)-20.46M
Levered Free Cash Flow (ttm)-20.97M